美第奇新星生物技术公布关于Mn-166(伊布地拉斯特)在ALS(Combat-ALS临床试验)中进行的2/3期临床试验随机患者基本特征的最新信息,发表在第36届国际ALS/MND研讨会上。
美第奇新星生物技术公布关于Mn-166(伊布地拉斯特)在ALS(Combat-ALS临床试验)中进行的2/3期临床试验随机患者基本特征的最新信息,发表在第36届国际ALS/MND研讨会上。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.